Catechol- O -Methyltransferase Gene Polymorphism Is Associated with Skeletal Muscle Properties in Older Women Alone and Together with Physical Activity
Paula H. A. Ronkainen, Eija Pöllänen, Timo Törmäkangas et al. · 2008
Read Catechol- O -Methyltransferase Gene Polymorphism Is Associated with Skeletal Muscle Properties in Older Women Alone and Together with Physical Activity by Paula H. A. Ronkainen, Eija Pöllänen, Timo Törmäkangas et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001819.txt.
Introduction
Paula H. A. Ronkainen, Eija Pöllänen, Timo Törmäkangas, and their co-authors studied a gene affecting muscle in older women in a 2008 PLOS ONE research article. Muscle strength declines on average by one percent a year from midlife. In postmenopausal women that decline coincides with a rapid drop in estrogen production. The genetics behind estrogen's effects on skeletal muscle remained unclear.
The team reports that a polymorphism in the COMT gene is associated with skeletal muscle properties in older women. The gene's full name is catechol-O-methyltransferase, and the effect appears alone and together with physical activity. The full text gives the muscle tests and the gene comparisons. Gene-activity interactions like this point toward exercise prescriptions tuned to a woman's genetic profile.
Catalog record
| CREATOR | Paula H. A. Ronkainen, Eija Pöllänen, Timo Törmäkangas et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001819
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Catechol- O -Methyltransferase Gene Polymorphism Is Associated with Skeletal Muscle Properties in Older Women Alone and Together with Physical Activity Authors: Paula H. A. Ronkainen, Eija Pöllänen, Timo Törmäkangas, Kristina Tiainen, Markku Koskenvuo, Jaakko Kaprio, Taina Rantanen, Sarianna Sipilä, Vuokko Kovanen Published: 2008, PLOS ONE DOI: 10.1371/journal.pone.0001819 ABSTRACT Muscle strength declines on average by one percent annually from midlife on. In postmenopausal women this decrement coincides with a rapid decline in estrogen production. The genetics underlying the effects of estrogen on skeletal muscle remains unclear. In the present study, we examined whether polymorphisms within COMT and ESR1 are associated with muscle properties and assessed their interaction and their combined effects with physical activity. A cross-sectional data analysis was conducted with 434 63-76-year-old women from the population-based Finnish Twin Study on Aging. Body anthropometry, muscle cross-sectional area (mCSA), isometric hand grip and knee extension strengths, and leg extension power were measured. COMT Val158Met and ESR1 PvuII genotypes were determined by the RFLP method. mCSA differed by COMT genotypes (p = 0.014) being significantly larger in LL than HL individuals in unadjusted (p = 0.001) and age- and height-adjusted model (p = 0.004). When physical activity and age were entered into GEE model, COMT genotype had a significant main effect (p = 0.038) on mCSA. Furthermore, sedentary individuals with the HH genotype had lower muscle mass, strength and power, but they also appeared to benefit the most from physical activity. No association of ESR1 PvuII polymorphism with any of the muscle outcomes was observed. The present study suggests that the COMT polymorphism, affecting the activity of the enzyme, is associated with muscle mass. Furthermore, sedentary individuals with potential high enzyme activity were the weakest group, but they may potentially benefit the most from physical activity. This observation elucidates the importance of both environmental and genetic factors in muscle properties. INTRODUCTION One of the most important functions of skeletal muscle is voluntary movement. Muscle also serves as an amino acid reservoir and a site for various metabolic activities participating e.g. to the glucose metabolism of the whole body [1] , [2] . Absolute muscle mass is again critical, when the body has to recover from critical illnesses or traumatic injuries [3] . From midlife on, muscle strength declines, approximately one percent annually [4] . This decline may eventually predispose people to mobility limitation, falls and bone fractures [5] – [7] . Individual differences in muscle phenotypes in old age may be explained by both environmental and genetic factors [8] – [12] . In women, menopause is characterized by rapid decline in the production of estrogen, an anabolic female sex hormone, and coincides with an accelerated deterioration in muscle performance [13] , [14] . At phenotype level hormone replacement therapy (HRT) exerts positive effects on skeletal muscle in some of the randomized, controlled trials reported [15] – [18] , whereas others have documented contradictory results [19] – [21] . Moreover, a combination of high-impact training and HRT usage has been reported to exceed the beneficial effects of HRT alone [15] . Furthermore, in animal studies estrogen has been shown to contribute to skeletal muscle growth via specific receptors [22] , [23] . Given this putative role of estrogen in muscle function, genes related to estrogen action and metabolism are likely candidates contributing to the genetic component of muscle properties. The synthesis and degradation of estrogens are mediated by several enzymes involved in multiple and complex metabolic pathways. After initial hydroxylation of estrogens by isoenzymes belonging to the cytochrome P450 family, they are further metabolized by catechol- O -methyltransferase (COMT) into more inactive methoxyestrogens. These O -methylated metabolites no longer bind to estrogen receptors (ESRs) [24] , which mediate the effects of estrogen in target tissues [25] . A functional G to A polymorphism in the fourth exon of COMT gene results in a valine to methionine amino acid transition at codon 158 (COMT Val158Met polymorphism) leading to thermolability [26] , [27] and lower activity of the enzyme. This could hence increase the availability of estrogen and induce the anabolic effects of this hormone on target tissues such as skeletal muscle. COMT represents an intracellular enzyme present in a variety of tissues [28] . Previous studies with men [29] , [30] , early pubertal girls [31] , as well as premenopausal [32] or postmenopausal women [33] – [35] have reported contradictory results, whether this polymorphism is actually associated with estrogen levels or not. To our knowledge, no studies have been published, in which the relationship of this polymorphism with skeletal muscle characteristics has been investigated. ESR1 was recently shown to be expressed in human skeletal muscle [36] implying that skeletal muscle is sensitive to estrogen signaling, albeit to date the overall effects of estrogen on skeletal muscle remain poorly understood. PvuII polymorphism in the first intron of ESR1 gene (ESR1 PvuII polymorphism) identifies a nucleotide T to C transition resulting in the loss of PvuII restriction site [37] , which has been suggested to affect the magnitude of ESR1 transcription or production of various ESR1 isoforms [38] . More precisely, the C variant, also denoted as the P allele, is suggested to lead to the amplification of ESR1 transcription. In previous reports, no association of this polymorphic site with isometric muscle strength has been found [39] , [40] . Theoretically, polymorphisms residing in genes related to estradiol metabolism and action, in this case COMT and ESR1 , may have shared effects on estradiol signaling in target tissues. More precisely, a polymorphism affecting the activity of COMT may directly or indirectly modulate the amount of estradiol available to be bound by membrane-bound or intracellular estrogen receptors, whereas a polymorphism potentially modulating the amount of ESR1 transcript may further affect the availability of these receptors. On the other hand, the two estrogen-related polymorphisms under investigation may act in conjunction with physical activity resulting in a specific muscle phenotype. Our aim was to determine whether the two estrogenic polymorphisms, COMT Val158Met and ESR1 PvuII, are associated with serum estradiol levels and skeletal muscle phenotypes or not. Furthermore, we studied the interaction of these polymorphisms and their interaction with physical activity. METHODS This study is a part of the Finnish Twin Study on Aging (FITSA), which investigates the genetic and environmental effects on the disablement process in older female twins. The detailed study design, including selection procedures, determination of zygosity and description of the participants, has been reported elsewhere [10] . Briefly, participants were recruited from the Finnish Twin Cohort [41] , [42] consisting of 13 888 twin pairs. 103 monozygotic and 114 dizygotic female twin pairs (total n = 434 subjects) aged 63–76 years (mean 68.6 years, SE 0.16) were invited to laboratory investigations performed in Jyväskylä during 2000–2001. Shared willingness to participate obtained from both sisters was a prerequisite for recruiting. Zygosity was determined with a battery of ten highly polymorphic gene markers using DNA extracted from a venous blood sample. The Ethics Committee of the Central Finland Hospital approved the study and it was conducted according to the guidelines in The Declaration of Helsinki. The subjects signed an informed consent before participating in the measurements. In the whole study sample the prevalence of various diseases potentially